ALNY
Alnylam Pharmaceuticals Inc
245.50$
+2.6%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.68 | 0.49 | 0.55 | 0.99 | 0.74 | 2.01 | 4.29 | 7.13 | 8.53 | 14.64 | 17.61 | 27.58 | |
| 3.09 | 3.93 | 5.40 | 6.38 | 0.02 | 0.23 | 0.68 | 1.18 | 1.39 | 2.49 | 2.53 | 5.03 | |
| 0.68 | 0.49 | 0.55 | 0.99 | 0.73 | 1.78 | 3.61 | 5.94 | 7.14 | 12.15 | 15.08 | 22.55 | |
| 2.56 | 3.29 | 4.47 | 4.31 | 5.02 | 6.00 | 5.69 | 6.69 | 7.26 | 8.04 | 8.82 | 9.83 | |
| 0.60 | 0.72 | 1.04 | 2.20 | 3.80 | 4.38 | 5.12 | 5.24 | 6.33 | 6.37 | 7.64 | 8.99 | |
| 3.16 | 4.01 | 5.51 | 6.52 | 8.83 | 10.38 | 10.81 | 11.93 | 13.59 | 14.41 | 16.46 | 18.82 | |
| -5.45 | -3.52 | -4.96 | -5.52 | -8.10 | -8.60 | -7.20 | -5.98 | -6.45 | -2.26 | -1.39 | 3.72 | |
| 0.03 | 0.07 | 0.10 | 0.14 | 0.29 | 0.99 | 0.73 | 1.21 | 1.28 | 0.97 | 1.11 | 1.88 | |
| -5.39 | -3.45 | -4.79 | -5.42 | -7.56 | -8.10 | -7.44 | -7.19 | -9.26 | -3.47 | -2.96 | 2.40 | |
| -0.54 | -0.30 | -0.27 | -0.28 | 0.01 | 0.01 | 0.02 | 0.01 | 0.03 | 0.05 | -0.78 | 0.07 | |
| -4.85 | -3.45 | -4.79 | -5.42 | -7.57 | -8.11 | -7.46 | -7.20 | -9.30 | -3.52 | -2.18 | 2.33 | |
| -2.32 | -3.30 | -4.78 | -5.37 | -7.50 | -8.10 | -6.40 | -5.59 | -7.61 | -2.07 | -1.40 | 4.69 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.